Explore the latest in atopic dermatitis, including advances in understanding the pathophysiology, diagnosis, and management of the disorder.
Two large matched cohort studies using health care data from England and Denmark investigate cancer risk in people with and without atopic eczema, including variation in risk associated with eczema severity and activity.
This cohort study examines the risk of keratinocyte carcinoma in adults with atopic dermatitis who receive topical calcineurin inhibitors.
This randomized clinical trial assesses the efficacy and safety of 4 mg and 2 mg of baricitinib in combination with background topical corticosteroid therapy in adults with moderate to severe AD who previously had an inadequate response to topical corticosteroid therapy.
This cross-sectional study examines the incidence of childhood allergies in women with varying levels of prepregnancy weight and gestational weight gain.
This systematic review uses data from randomized clinical trials obtained via MEDLINE, Embase, Cochrane Central Register, and ClinicalTrials.gov to investigate the inclusion of older adults in studies pertaining to systemic medication used in the treatment of atopic dermatitis.
This randomized clinical trial investigates the efficacy and safety of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis.
This systematic review and network meta-analysis compares the effectiveness and safety of systemic immunomodulatory treatments for adult patients with atopic dermatitis.
This phase 2b, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targeting interleukin (IL)–13 that selectively prevents formation of the IL-13Rα1/IL-4Rα heterodimer receptor signaling complex, in adults with moderate to severe atopic dermatitis.
This case report describes a 32-year-old woman with Netherton syndrome, which caused polycyclic serpiginous, erythematous plaques with double-edged scale on her trunk and extremities.
This systematic review and meta-analysis investigates the risk of noncutaneous and cutaneous cancers in patients with atopic dermatitis compared with the general population without atopic dermatitis.
This randomized clinical trial of patients previously treated with dupilumab for atopic dermatitis assesses the efficacy of different dupilumab regimens in maintaining response after 16 weeks of initial treatment.
This phase 3 randomized clinical trial evaluates the efficacy and safety of 2 dose regimens of dupilumab for treatment of moderate to severe atopic dermatitis in adolescents.
This randomized clinical trial investigates the application of anti-IgE therapy vs placebo to alleviate the symptoms of severe eczema in children.
This randomized clinical trial investigates the efficacy and safety of once-daily oral abrocitinib, a Janus kinase 1 selective inhibitor, for patients with moderate to severe atopic dermatitis.
This cross-sectional study examines whether tape strips might be used to detect immune and barrier abnormalities and to define biomarkers associated with atopic dermatitis in children younger than 5 years with early-onset atopic dermatitis.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: